Company Expects to Seek Relisting on Over-the-Counter Bulletin Board
WORCESTER, Mass.-- (BUSINESS WIRE)--Advanced Cell Technology, Inc. (Advanced Cell, ACT) (OTC: ACTC) announced today that it has filed its Form 10-Q for the first quarter ended March 31, 2009. The filing brings the Company's financial statements current. The Company plans to seek relisting on the Over-the-Counter Bulletin Board.
"We are pleased that we have been able to bring our financial statements current, which represents an important step in relisting on the Over-the-Counter Bulletin Board and in providing the investment community with up-to-date information on the Company's financial condition,” said William Caldwell, CEO of Advanced Cell. "I also want to express my gratitude to the Company's employees for their tireless efforts in helping the Company compile the requisite financial information, and to Dr. Robert Lanza, Advanced Cell's Chief Scientific Officer, and his research and development team who have made significant scientific progress, despite the Company and industry's financial challenges. Through their efforts ACT is on track to file an IND with the Food and Drug Administration for its retinal pigment epithelium cell therapeutic program for the treatment of diseases of the eye the second half of this year.”
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.com.
Forward-Looking Statements
Statements in this news release regarding future ability to draw on the credit Facility, future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the Company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will,” "believes,” "plans,” "anticipates,” "expects,” "estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: the Company's ability to meet all of the conditions to allow it to access the entire amount available under the credit Facility discussed in this press release, limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended September 30, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Contact:
Advanced Cell Technology
Dan Schustack
CEOcast, Inc. for Advanced Cell Technology
212-732-4300
Frequently Requested Info